Abemaciclib mesylate is a salt form of abemaciclib, an orally available cyclin-dependent kinase (CDK) inhibitor that targets CDK4 and CDK6, with potential antineoplastic activity. It inhibits retinoblastoma protein phosphorylation, thereby arresting the cell cycle in the G1 phase and suppressing cancer cell growth.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1231930-82-7
Abemaciclib
cell cycle inhibitor
Ganirelix
gonadotropin-releasing hormone antagonist
Clofarabine
antineoplastic antimetabolite nucleoside metabolic inhibitor
25-Hydroxycholecalciferol, 5-trans-
active pharmaceutical ingredient
Azane;N-[1-[4-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-phenoxyphenyl]ethyl]acetamide;formic acid;methane;pentadecahydrate;dihydrochloride
active pharmaceutical ingredient
N-[5-[(4-ethylpiperazin-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;methanesulfonic acid
NCJPFQPEVDHJAZ-UHFFFAOYSA-N
CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F.CS(=O)(=O)O